Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway
Kynurenine (Kyn) is a key inducer of an immunosuppressive tumor microenvironment (TME). Although indoleamine 2,3-dioxygenase (IDO)-selective inhibitors have been developed to suppress the Kyn pathway, the results were not satisfactory due to the presence of various opposing mechanisms. Here, we empl...
Guardado en:
Autores principales: | Jeong Hun Kim, Won Suk Lee, Hye Jin Lee, Hannah Yang, Seung Joon Lee, so Jung Kong, Soyeon Je, Hyun-Jin Yang, Jongsun Jung, Jaekyung Cheon, Beodeul Kang, Hong Jae Chon, Chan Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b79d3c54e4ff44589373a0cee089c2d6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Function of the Kynurenine Pathway in the Placenta: A Novel Pharmacotherapeutic Target?
por: Michelle Broekhuizen, et al.
Publicado: (2021) -
Serum profiles of tryptophan-kynurenine pathway metabolites in psoriasis
por: Mariko Seishima, et al.
Publicado: (2021) -
TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
por: V. A. Kozlov, et al.
Publicado: (2017) -
Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System
por: Corina Bello, et al.
Publicado: (2021) -
Electrochemical Determination of Kynurenine Pathway Metabolites—Challenges and Perspectives
por: Ilona Sadok, et al.
Publicado: (2021)